Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 28,370 | 27,356 | 14,308 | 6,918 | 0 |
| Gross Profit | 28,370 | 27,356 | 14,308 | 6,918 | N/A |
| Operating Expenses | 17,264 | 17,644 | 17,461 | 19,032 | 0 |
| Operating Income | 11,106 | 9,712 | -3,153 | -12,114 | N/A |
| Interest Expense | 0 | 64 | 93 | 91 | 0 |
| Other Income | 1,912 | 2,384 | -1,055 | 224 | 0 |
| Pre-tax Income | 13,018 | 12,032 | -4,301 | -11,981 | 0 |
| Net Income Continuous | 13,018 | 12,032 | -4,301 | -11,981 | N/A |
| Net Income | $13,018 | $12,032 | $-4,301 | $-11,992 | $N/A |
| EPS Basic Total Ops | 4.11 | 2.87 | -3.24 | -1.86 | N/A |
| EPS Basic Continuous Ops | 4.11 | 8.99 | -3.24 | -1.86 | N/A |
| EPS Diluted Total Ops | 3.28 | 1.91 | -3.24 | -1.86 | N/A |
| EPS Diluted Continuous Ops | 3.28 | 5.99 | -3.24 | -1.86 | N/A |
| EBITDA(a) | $11,844 | $10,417 | $-2,367 | $-10,982 | $N/A |